alnylam
The Vice President, Program Management at Alnylam leads the global program management organization across research, development, and commercial portfolios, driving operational excellence, standardizing tools and processes, and ensuring successful program milestones. This senior leader partners with program leaders and cross‑functional teams to optimize resource allocation, improve organizational effectiveness, and foster a high‑performing, accountable culture.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
51% above the average for this role
Vice President, Program Management
kaileratherapeutics
Senior Vice President, Portfolio Operations
Aditum Bio
Assistant Vice President, Portfolio Management
Sun Life
Vice President of Program Management
SAB
Vice President, Program and Portfolio Management
Septerna
Project Vice President, Portfolio Management
Zealand Pharma